105 related articles for article (PubMed ID: 19897066)
1. A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus.
Van de Walle GR; May MA; Peters ST; Metzger SM; Rosas CT; Osterrieder N
Vaccine; 2010 Jan; 28(4):1048-55. PubMed ID: 19897066
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel equine influenza virus live-attenuated vaccine.
Rodriguez L; Reedy S; Nogales A; Murcia PR; Chambers TM; Martinez-Sobrido L
Virology; 2018 Mar; 516():76-85. PubMed ID: 29331866
[TBL] [Abstract][Full Text] [Related]
3. Impact of the host immune response on the development of equine herpesvirus myeloencephalopathy in horses.
Giessler KS; Goehring LS; Jacob SI; Davis A; Esser MM; Lee Y; Zarski LM; Weber PSD; Hussey GS
J Gen Virol; 2024 May; 105(5):. PubMed ID: 38767608
[TBL] [Abstract][Full Text] [Related]
4. Vaccination for the prevention of equine herpesvirus-1 disease in domesticated horses: A systematic review and meta-analysis.
Osterrieder K; Dorman DC; Burgess BA; Goehring LS; Gross P; Neinast C; Pusterla N; Hussey GS; Lunn DP
J Vet Intern Med; 2024; 38(3):1858-1871. PubMed ID: 37930113
[TBL] [Abstract][Full Text] [Related]
5. Immunization with Attenuated Equine Herpesvirus 1 Strain KyA Induces Innate Immune Responses That Protect Mice from Lethal Challenge.
Kim SK; Shakya AK; O'Callaghan DJ
J Virol; 2016 Sep; 90(18):8090-104. PubMed ID: 27356904
[TBL] [Abstract][Full Text] [Related]
6. Viremia and nasal shedding for the diagnosis of equine herpesvirus-1 infection in domesticated horses.
Pusterla N; Dorman DC; Burgess BA; Goehring L; Gross M; Osterrieder K; Soboll Hussey G; Lunn DP
J Vet Intern Med; 2024; 38(3):1765-1791. PubMed ID: 38069548
[TBL] [Abstract][Full Text] [Related]
7. Monophosphoryl lipid A and poly I:C combination enhances immune responses of equine influenza virus vaccine.
Lee DH; Lee J; Ahn SY; Ho TL; Kim K; Ko EJ
Vet Immunol Immunopathol; 2024 May; 271():110743. PubMed ID: 38522410
[TBL] [Abstract][Full Text] [Related]
8. Assessment of antigenic difference of equine influenza virus strains by challenge study in horses.
Yamanaka T; Nemoto M; Bannai H; Tsujimura K; Kondo T; Matsumura T; Gildea S; Cullinane A
Influenza Other Respir Viruses; 2016 Nov; 10(6):536-539. PubMed ID: 27465864
[TBL] [Abstract][Full Text] [Related]
9. Studying longitudinal neutralising antibody levels against Equid herpesvirus 1 in experimentally infected horses using a novel pseudotype based assay.
Di Genova C; Sutton G; Paillot R; Temperton N; Pronost S; Scott SD
Virus Res; 2024 Jan; 339():199262. PubMed ID: 37931881
[TBL] [Abstract][Full Text] [Related]
10. Change to primary course equine influenza vaccine rules.
White GM
Vet Rec; 2024 Jan; 194(2):67. PubMed ID: 38240418
[No Abstract] [Full Text] [Related]
11. Systematic Review of Equine Influenza A Virus Vaccine Studies and Meta-Analysis of Vaccine Efficacy.
Elliott S; Olufemi OT; Daly JM
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140577
[TBL] [Abstract][Full Text] [Related]
12. Updated ACVIM consensus statement on equine herpesvirus-1.
Lunn DP; Burgess BA; Dorman DC; Goehring LS; Gross P; Osterrieder K; Pusterla N; Soboll Hussey G
J Vet Intern Med; 2024; 38(3):1290-1299. PubMed ID: 38497217
[TBL] [Abstract][Full Text] [Related]
13. Genomic characterization of equine influenza A subtype H3N8 viruses by long read sequencing and functional analyses of the PB1-F2 virulence factor of A/equine/Paris/1/2018.
Kleij L; Bruder E; Raoux-Barbot D; Lejal N; Nevers Q; Deloizy C; Da Costa B; Legrand L; Barrey E; Chenal A; Pronost S; Delmas B; Dhorne-Pollet S
Vet Res; 2024 Mar; 55(1):36. PubMed ID: 38520035
[TBL] [Abstract][Full Text] [Related]
14. Antibody response to Influenza booster vaccination in Franches-Montagnes stallions supplemented with Equi-Strath
van Dorland HA; Zanoni R; Gerber V; Jeannerat E; Wiederkehr D; Burger D
Vet Med Sci; 2018 May; 4(2):133-139. PubMed ID: 29851307
[TBL] [Abstract][Full Text] [Related]
15. Equine herpesvirus type 1 (EHV-1) replication at the upper respiratory entry site is inhibited by neutralizing EHV-1-specific IgG1 and IgG4/7 mucosal antibodies.
Eady NA; Holmes C; Schnabel C; Babasyan S; Wagner B
J Virol; 2024 May; ():e0025024. PubMed ID: 38742875
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic interventions for the treatment of equine herpesvirus-1 in domesticated horses: A systematic review.
Goehring L; Dorman DC; Osterrieder K; Burgess BA; Dougherty K; Gross P; Neinast C; Pusterla N; Soboll-Hussey G; Lunn DP
J Vet Intern Med; 2024; 38(3):1892-1905. PubMed ID: 38380685
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of immunogenicity and protective efficacy of bacteriophage conjugated haemagglutinin based subunit vaccine against equine influenza virus in a murine model.
Kumar R; Bera BC; Anand T; Pavulraj S; Kurian Mathew M; Gupta RP; Tripathi BN; Virmani N
Vet Res Commun; 2024 Mar; ():. PubMed ID: 38528300
[TBL] [Abstract][Full Text] [Related]
18. Equine gamma herpesvirus presence and viral load are not associated with equine glandular gastric disease.
Thompson RN; Pearson E; McDonough SP; Iannitti H; Van de Walle GR; Banse H; Perkins GA; Tomlinson JE
Am J Vet Res; 2024 Mar; ():1-9. PubMed ID: 38484465
[TBL] [Abstract][Full Text] [Related]
19. Temporary suppression of cell-mediated immunity in standardbred horses with decreased athletic capacity.
Jensen-Waern M; Persson SG; Nordengrahn A; Mérza M; Fossum C
Acta Vet Scand; 1998; 39(1):25-33. PubMed ID: 9592943
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a new equine embryo brain primary cell culture with long-term expansion.
Kasem S; Abdel-Moneim AS; Fukushi H
J Virol Methods; 2024 May; 328():114952. PubMed ID: 38754768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
